24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Chiasma
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
18:20
Two weeks before Israel's elections, WhatsApp exchanges attributed to Netanyahu's right-hand man leak online
15:47
From promised returns to financial distress: Israeli investors hit by overseas real estate slump
15:31
Israel weighs U.S.-style tax break for high-tech entrepreneurs
15:13
American buyer pays $18 million for Tel Aviv penthouse
More stories
Buzz
Most popular
Daily
Weekly
1
U.S. Army deploys Elbit's Iron Fist defense system against missiles and drones
2
Israel loses $1 billion Apache deal after failing to find $288 million in funding
3
Flydubai passengers prepare lawsuits seeking hundreds of millions of dollars
4
HubSpot cuts nearly 660 jobs as AI reshapes its business
5
Israeli startup raises $5 million to rethink one of surgery's most invasive procedures
More news
Chiasma
1 stories about Chiasma
Nasdaq-Listed Biopharma Company Chiasma Raises $34.5 Million in Public Offering
09.04.19
|
CTech
Chiasma develops octreotide capsules for the treatment of acromegaly, a rare, chronic disease typically caused by a benign tumor of the pituitary gland